Skip to main contentLast updated: 04-Nov-2026
Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Rectal Cancer Surgeon
Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad · 18 years of experience
In short
Stage IV rectal cancer means the cancer has travelled beyond the pelvis, most often to the liver or lungs. It is treated mainly with drugs, and sometimes with surgery as well.
Gene tests on the biopsy pick the drugs. They are the first step, before any treatment begins.
If the spread is limited, all visible disease may still be removed. If not, the aim is to control the cancer and keep you well.
Surgery for the rectum itself is explained on the middle rectal cancer surgery page. This post is about cancer that has spread.
Stage IV means cancer cells from the rectum have reached another organ. The liver is the usual place, then the lungs. Some people have this at the first visit, others after earlier treatment.
Rectal cancer that has spread is treated much like colon cancer that has spread. The rectum adds one more question, which is what to do about the tumour in the pelvis.
Our post on how rectal cancer is staged explains the scans used.
Four tests on the biopsy decide the drugs: mismatch repair (MSI), RAS, BRAF and HER2. They should be done before the first treatment.
| Test | What it looks for | How it changes the plan |
|---|---|---|
| Mismatch repair (MSI) | A fault in the gene repair system | May open the door to immunotherapy as the first treatment |
| RAS (KRAS, NRAS) | A change that switches growth signals on | If present, anti-EGFR drugs will not work. If absent, they can be used |
| BRAF V600E | A change that makes cancer grow fast | Needs a stronger first plan, or a special targeted pair of drugs |
| HER2 | Too many copies of the HER2 gene | A rare group that may respond to HER2-blocking drugs |
These results can change the whole plan. Do not start drugs until they are back, unless the situation is urgent. Our post on what the pathology report says explains each test.
Sometimes, yes. When the spread is limited to a few spots in one organ, a plan of chemotherapy plus surgery can remove all visible disease. This is the most hopeful route in stage IV.
This is a team decision between the surgeon, the medical oncologist and the radiologist. Our page on colorectal liver metastases explains the liver part in detail.
If the rectal tumour bleeds, blocks the bowel or causes pelvic pain, it needs attention early. If it causes no trouble, drugs usually come first and the tumour is checked again later.
| Situation | Usual approach |
|---|---|
| Tumour causes little trouble, spread causes symptoms | Drugs first. Review the rectal tumour after two to three months |
| Bowel is blocked or nearly blocked | A stoma, a stent, or removal of the tumour |
| Heavy bleeding, pain or infection from the tumour | Short course radiation, or surgery if needed |
| Spread is limited and can be removed | Drugs plus surgery for all disease, including the rectum |
A small group of stage IV rectal cancers are MSI-high. These respond well to immunotherapy, so the immune drug is given first instead of chemotherapy.
Most people start with a chemotherapy combination, often with a targeted drug added. The choice depends on the gene tests, your fitness and how fast the cancer is growing.
Drug breaks are common when the cancer is under control. A break gives your body time to recover. Your oncologist will tell you when it is safe.
Several trials changed the care of stage IV bowel cancer. They tested immune drugs, targeted pairs and later-line drugs. Most enrolled colon and rectal cancer together.
| Trial | What it tested | What it showed |
|---|---|---|
| KEYNOTE-177 | Pembrolizumab against chemotherapy in MSI-high cancer | People lived longer without the cancer growing, with fewer side effects |
| BEACON CRC | Encorafenib plus cetuximab in BRAF V600E cancer | Longer survival than usual chemotherapy |
| MOUNTAINEER | Tucatinib plus trastuzumab in HER2-high cancer | A good share of people had their tumours shrink |
| CodeBreaK 300 | Sotorasib plus panitumumab in KRAS G12C cancer | Tumours shrank more often than with standard drugs |
| FRESCO-2 | Fruquintinib after other drugs had stopped working | Longer survival than placebo |
Rectal-only results are often too small to read on their own. Our post on key trials in rectal cancer goes through the trials one by one.
Cancer that returns in the pelvis after treatment is a special problem. It needs fresh scans and a team decision. Some people can have a major operation to remove it.
Results of these operations depend a great deal on the centre. Ask how often the team does them. Our post on special situations in rectal cancer covers related problems.
HIPEC has a very small role in rectal cancer. Cancer that spreads to the lining of the belly is uncommon from the rectum, and a large trial in bowel cancer did not show benefit.
It is considered only in rare cases, such as a mucus-producing tumour in the upper rectum with disease limited to the belly lining. Such cases are handled at centres that treat peritoneal surface cancers.
It means the cancer has spread from the rectum to another organ, most often the liver or lungs. It is treated mainly with drugs, and sometimes with surgery as well.
The biopsy is tested for MSI, RAS, BRAF and HER2. These results choose the drugs, so they should be back before treatment starts.
Sometimes. If the spots are few and all can be removed, a plan of chemotherapy and surgery can take out all visible disease. A team decides this after reading the scans.
Not always. If the tumour causes little trouble, drugs usually come first. Surgery, a stoma, a stent or radiation is used when the tumour bleeds, blocks the bowel or hurts.
An immune drug such as pembrolizumab is usually given first, instead of chemotherapy. A medical oncologist leads this treatment.
Many are, but supply and cost differ. Ask your oncologist about access and the total cost before you start, so the plan can be kept up.
In some fit people, yes. The cancer is mapped with MRI and PET-CT. A few may be offered a major operation at an experienced centre. Others are treated with drugs or radiation.
The full range of rectal cancer care starts at the middle rectal cancer page. For questions before you travel, call +91-63555-64601.
Dr Harsh Shah — Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
Dr. Jivraj Mehta Hospital, Dr Jivraj Mehta Marg, Vasna, Ahmedabad 380007.
Consultations, review of reports and scans, operations and follow-up. OPD Monday to Saturday, 9 am to 5 pm.
Appointments: +91-63555-64601 · +91-63590-11009 · Hospital 079-2663 6363
Directions to the hospital · WhatsApp +91-63555-64601
Has a scan shown that rectal cancer has reached the liver, lungs or glands? This is serious, but it is not the end of options. Many people still have a clear plan. Bring your scans, biopsy and any gene test reports. Dr Harsh Shah will explain what can be done and in what order. Call, or send a message on WhatsApp. Call +91-63555-64601 Ask on WhatsApp
Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.